Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study. (Record no. 25610155)

MARC details
000 -LEADER
fixed length control field 01694 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517072854.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201610s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1479-6821
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1530/ERC-15-0490
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Caplin, Martyn E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20161024
245 00 - TITLE STATEMENT
Title Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Endocrine-related cancer
Date of publication, distribution, etc. Mar 2016
300 ## - PHYSICAL DESCRIPTION
Extent 191-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intestinal Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuroendocrine Tumors
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatic Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Peptides, Cyclic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Somatostatin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pavel, Marianne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ćwikła, Jarosław B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Phan, Alexandria T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raderer, Markus
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sedláčková, Eva
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cadiot, Guillaume
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wolin, Edward M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Capdevila, Jaume
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wall, Lucy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rindi, Guido
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Langley, Alison
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Martinez, Séverine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gomez-Panzani, Edda
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ruszniewski, Philippe
773 0# - HOST ITEM ENTRY
Title Endocrine-related cancer
Related parts vol. 23
-- no. 3
-- p. 191-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1530/ERC-15-0490">https://doi.org/10.1530/ERC-15-0490</a>
Public note Available from publisher's website

No items available.